Strategizing and Executing your Exit for the Greater Good of your Team
About this episode
Tim Wentworth, Retired CEO, Evernorth
Selling a business can be challenging for a founder. Regardless of the reasons behind an exit, there are ways to ensure a company's continuity and success.
In this episode of the M&A Science Podcast, Tim Wentworth, Retired CEO of Cigna, formerly known as Express Scripts, discusses how to strategize and execute an exit for a team's greater good.
Liked today's episode? Unlock over 60 courses taught by top-tier M&A practitioners by joining the M&A Science Academy. Use code "academy20%" on the sign-up page for a 20% discount, available on either monthly or annual plans. https://www.mascience.com/academy
Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup
If you're a head of corporate development and looking to build up a world-class M&A team, reach out to me at [email protected].
This episode is sponsored by DealRoom: faster diligence and integration in one combined process. See how DealRoom produces more value in less time by going to www.dealroom.net
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science
Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science
Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science
Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science
Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science